Clinical Director and Founder & CEO attended Bioequivalence Symposium, Biological and Non-Biological Complex Drugs


Eszter Fodor, MD, Clinical Director and Peter Ferdinandy, MD, PhD, MBA, Founder & CEO has attended the 3rd International Symposium on Scientific and Regulatory Advances in Biological and Non – Biological Complex Drugs: A to Z in Bioequivalence held in Budapest between November 12-14, 2018.

Learn more about how your Medicinal Product, Medical Device, In Vitro Diagnostic, and Advanced Therapy Medicinal Product development project can benefit from our innovative preclinical and clinical R&D services by contacting us!